发明名称 |
FUSED HETEROCYCLIC COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR |
摘要 |
<p>Disclosed are fused heterocyclic compounds that are useful for prophylaxis, therapy or amelioration of diseases on which a thrombopoietin receptor activation effect is effective. Specifically disclosed are a fused heterocyclic compound represented by formula (I) (wherein R1 represents an aryl group that is fused to a saturated ring, or the like; and A, B, L1, R2, L2, L3, Y, L4, R3 and X are as defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound, and a solvate of the compound, tautomer, prodrug or pharmaceutically acceptable salt.</p> |
申请公布号 |
WO2011049213(A1) |
申请公布日期 |
2011.04.28 |
申请号 |
WO2010JP68754 |
申请日期 |
2010.10.22 |
申请人 |
NISSAN CHEMICAL INDUSTRIES, LTD.;SHIGETA, YUKIHIRO;UMEZAWA, SHINGO;IWAMOTO, SHUNSUKE;NAKAMURA, TAKANORI |
发明人 |
SHIGETA, YUKIHIRO;UMEZAWA, SHINGO;IWAMOTO, SHUNSUKE;NAKAMURA, TAKANORI |
分类号 |
C07D231/18;A61K31/381;A61K31/41;A61K31/415;A61K31/4155;A61K31/4439;A61K31/454;A61P7/06;A61P7/08;A61P9/10;A61P43/00;C07D333/32;C07D401/12;C07D409/04;C07D409/12;C07D409/14 |
主分类号 |
C07D231/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|